According to a new market report published by
Lucintel, the future of the global wearable medical device market looks promising
with opportunities in home healthcare and remote patient monitoring. The global
wearable medical device market is expected to reach an estimated $9.4 billion
by 2022 and it is forecast to grow at a CAGR of 14.9% from 2017 to 2022. The
major drivers of growth are increasing awareness and importance of fitness and
healthy lifestyle, rising chronic diseases, and technological innovations.
In this market, diagnostic wearable and
therapeutic wearable are the main segments by application type. On the basis of
its comprehensive research, Lucintel forecasts that diagnostic wearable device is
expected to show highest growth during the forecast period from 2017 to 2022.
Healthcare and remote patient monitoring are
the major segments of global wearable medical device end use market and remote
patient monitoring is expected to show above average growth during the forecast
period due to its advanced wireless communication technologies to share patient
medical records and activity with doctors over a period of time.
North America is expected to remain the
largest as well as the highest growth region due to high disposable income,
rising chronic conditions and acceptance of technologically advanced products in
this region.
Emerging trends, which have a direct impact on
the dynamics of the market, include the increasing usage of wearable
biofeedback devices and increasing adoption of cloud technology for
interconnected healthcare devices. Medtronic Plc, Roche Holding AG, and Animas
Corporation (Johnson & Johnson) are the major manufacturers of the wearable
medical device market.
Lucintel, a leading
global strategic consulting and market research firm, has analyzed growth
opportunities in the global wearable medical device market by end use, application, distribution channel and region,
and compiled a comprehensive research report entitled “Growth
Opportunities in the Global Wearable Medical Device Market 2017-2022: Trends,
Forecast, and Opportunity Analysis.”
The Lucintel report serves as a catalyst for growth strategy by providing comprehensive
data and analysis on trends, key drivers, and directions. The study includes a
forecast for the growth opportunities in the global wearable medical device market
by end use type, application, distribution channel and region, as follows:
By Application [Value ($ million) from 2011 to
2022]:
- Diagnostic
o
Vital Sign Monitoring
o
Neuromodulation
o
Fetal and Obstetric
- Therapeutic
o
Pain Management Wearables
o
Diabetic
o
Rehabilitation
o
Respiratory
By End Use Market [Value $ million from 2011
to 2022]:
- Healthcare
- Remote Patient Monitoring
By Distribution Channel [Value $ million from 2011 to 2022]:
- Pharmacy and Clinics
- Others and Online
By Region [Value ($ million) and
Volume (million units) from 2011 to
2022]:
- North America
o
US
o
Canada
o
Mexico
- Europe
o
United Kingdom
o
Germany
o
France
o
Spain
o
Italy
- Asia Pacific
o
China
o
Japan
o
Australia
o
S. Korea
- The Rest of the World
o
Latin America
o
Middle East
This 163 page research report will enable you to make confident business decisions in this
globally competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or helpdesk@lucintel.com. Lucintel offerings include medical market analysis,
medical market research, commercial due diligence report, business strategy consulting and
market research reports online.
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity analysis, growth consulting, M&A, and due diligence
services to executives and key decision-makers in a variety of industries. For
further information, visit www.lucintel.com.
This
report addresses the following key questions:
Q. 1. What are some
of the most promising, high-growth opportunities for the global wearable
medical device market by end use (healthcare, remote patient monitoring), application
(diagnostic and therapeutic), distribution channel (pharmacy/clinics, online,
and others), and region (North America, Europe, APAC, and the Rest of the
World)?
Q. 2. Which
segments will grow at a faster pace and why?
Q. 3. Which region will
grow at a faster pace and why?
Q.4. What are
the key factors affecting market dynamics? What are the drivers, challenges, and
business risks in this market?
Q.5. What are the business risks and competitive threats
in this market?
Q.6. What
are the emerging trends in this market and reasons behind them?
Q.7. What
are some changing customer demands in the market?
Q.8. What are
the new developments in the market? Which companies are leading these
developments?
Q.9. Who are the
major players in this market? What are the strategic initiatives of key players
for business growth?
Q.10. What are
some of the competing products in this market and how big of a threat do they
pose for loss of market share by material / product substitution?
Q.11. What M&A
activity has occurred in the last 5 years?
No comments:
Post a Comment